skip to Main Content

Cancer Services

Gynaecological Cancer

Please see below all current gynaecological cancer clinical trials of the Central Coast Cancer Centre.

Name: ICON 9

An international phase III randomised study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olapartib alone in patients with relapsed platinum sensitive-ovarian cancer following a response to platinum-based chemotherapy.

Principal Investigator: Dr Craig Kukard
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Ovarian Cancer

More information about ICON 9

More information

For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Back To Top